PAR1: COST OF ASTHMA IN CHILDREN IN VLADIVOSTOK  by Prosekova, E et al.
Abstracts 75
pared to those with low or no GC exposure. These find-
ings provide new evidence that vertebral fractures have
substantial increases on treatment costs among GC pa-
tients. Also, greater PMPM increases from vertebral frac-
tures among high GC patients versus low GC patients
suggest vertebral fractures increase in severity with GC
exposure. These results also support the need for adju-
vant therapy to reduce fracture risk and associated mor-
bidities.
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OBJECTIVES: Estimation the cost of asthma in children
in Vladivostok. METHODS: In cost of disease we deter-
mined direct expenses: pharmacotherapy, hospital, out-
patient and emergency expenditures; indirect expenses:
disability pension, temporary invalidity of parents and
quality of child’s life with asthma in Vladivostok during
1995–1998. 645 families with asthmatic children filled in
a questionnarie. RESULTS: Family expenses on pharma-
cotherapy of asthmatic child during the 1996 year aver-
aged 1520,81 roubles (rb) ($303), in 1998—increased to
2149,45 rb at the expense of basic therapy. In 1996 di-
rect family expenses on asthmatic child was 10,98 
1,33% of annual income, in 1998—13,70  1,46% and
bulk of the expenditures was pharmacotherapy. 1159
children with asthma in 1995 had 618 cases of hospital-
ization, total duration was 16 058 days. One child with
asthma in 1995 year had 13,64  1,0 days of hospitaliza-
tion, in 1998—8,81  0,92. Volume of hospitalization
depended on heaviness of disease. In 1996 among 22 651
emergency cases in city 230 (1,02%) was to asthmatic
children. In 1998 this index was decreased to 109. In
1996 out-patient expenses one asthmatic child was
223,05  32,50 rb, in 1998—272,46  36,96 rb. In
1997–1998 expenses for allergologist and pulmonologist
are increased. In 1996 among 1028 asthmatic children 37
got disability pension (270 rb in month). Total family ex-
penses on asthmatic child in Vladivostok in 1996 was
4070,84  86,70 rb ($810,83  10,63), in 1997—
4767,58  69,94 rb ($821,99  8,46), in 1998—
4203,58  46,24 rb. In 1996 on asthmatic child in Vladi-
vostok bulk of the expenditures was hospitalization, in
1998—pharmacotherapy. CONCLUSION: Introduction
in Vladivostok in 1997–1998 the National program of
treatment asthma in children resulted in wide use of basic
therapy, increasing family expenses asthmatic child on
pharmacotherapy and decreasing municipal expenses on
hospitalization, emergency care and indirect losses of
family.
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OBJECTIVES: To identify factors associated with the in-
crease in the use of bilevel positive pressure ventilators
with timed backup in the Medicare population from
1996 through 1999. METHODS: We extracted durable
medical equipment claims for bilevel positive pressure
ventilators with and without timed backup (RAD and
RAD-timed, respectively), continuous positive airway
pressure devices (CPAP) and oxygen supplies (gas, liquid,
concentrator) from the 1994–1999 claims files for 5% of
Medicare beneficiaries, and compared disease prevalence,
oxygen use, and other factors in the different user groups.
RESULTS: Between 1994 and 1998, new use increased
for both RAD and RAD-timed devices, but was signifi-
cantly greater for the latter. Oxygen use remained rela-
tively stable among CPAP and RAD users, but increased
in RAD-timed users. RAD-timed users were more likely
than RAD users to have claims for oxygen (80% vs.
44%), or diagnoses suggesting chronic lung disease (86%
vs. 35%) in the first year of device use; RAD users were
more likely to have a diagnosis of sleep apnea/other sleep
disorder in the first year of use (73% vs. 14%). CON-
CLUSIONS: Debate continues over appropriate indica-
tions, servicing and reimbursement for respiratory assist
devices, particularly those with timed backup. RAD and
RAD-timed device users differ significantly. The high
prevalence of COPD diagnoses reflects current interest in
the use of these devices in the long-term treatment of this
disorder; other indications suggested in the literature,
such as respiratory support in neuromuscular disorders
or congestive heart failure, appeared rarely. Growth in
the use of the more costly RAD-timed devices among
oxygen users varied by region as well as by year, possibly
reflecting regional differences in coverage, medical prac-
tice or marketing. Person-level, longitudinal analysis of
claims data supports the development and implementa-
tion of coverage and payment policies, by helping to de-
lineate the demographic and clinical characteristics of
user groups.
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OBJECTIVE: The objective of this analysis was to evalu-
ate the impact of social class on correlation between the
standardized AQLQ, self-rated asthma severity and con-
